Accueil   Agenda - News   Toutes les news Adocia Launches Phase III Clinical Study in India

Adocia Launches Phase III Clinical Study in India

Adocia announced the initiation of a clinical Phase III study in India of BioChaperone® PDGF-BB, the Company’s innovative formulation of Platelet Derived Growth Factor (PDGF-BB) for the treatment of diabetic foot ulcers. This follows the approval given by the Drug Controller General of India (DCGI) on August 22nd, 2014. The dossier for this clinical trial was filed in September 2012, but the processing of the application had been delayed by the internal reorganization of the Indian regulatory agency.

 

Read the press release

 

 

Adocia